The company's profit in Q4 has increased from Rs 87.5 crore to Rs 959.5 crore, while the market was expecting a profit of around Rs 1,100 crore
Besides five drug companies that had tie-ups, Russian firms says they are looking for a couple of more firms for the possible production pacts